Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Channel Therapeutics Corp CHRO

Healthcare Biotechnology
Channel Therapeutics Corporation, formerly Chromocell Therapeutics Corporation, is a clinical-stage biotech company, which is focused on developing and commercializing therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel, NaV1.7, which has been genetically validated as a pain receptor in human physiology. It operates three programs developing pain... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:CHRO)

Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine 

GlobeNewswire December 20, 2024

Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model

GlobeNewswire December 18, 2024

Chromocell Announces Name Change to "Channel Therapeutics Corporation" and Provides Therapeutic Program Updates

GlobeNewswire November 21, 2024

Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain

GlobeNewswire October 29, 2024

Chromocell to Present at Upcoming Fall Investor Conferences

GlobeNewswire October 28, 2024

Chromocell Announces Amendment to Stock Repurchase Plan

GlobeNewswire October 24, 2024

Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire September 3, 2024

Chromocell Announces Stock Repurchase Plan

GlobeNewswire August 7, 2024

Chromocell to Participate in the Virtual Investor Lunch Break Series

GlobeNewswire July 15, 2024
View More News ››

Opinion & Analysis (NYSEAM:CHRO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:CHRO)

Sold out of this stock today.

It was a good time for me to get out of this one.It was a big triple for me in the price per share.So that my sell order at the $3.39...
coolfooldumbguy - January 21, 2025

Buy buddy buy because it's taking off this morning.

Hey you guys.
coolfooldumbguy - January 21, 2025

Big buy for me today.

My buy order at $1.13 cents per share was completed today.
coolfooldumbguy - January 17, 2025

CHRO...this was a $6 IPO on NYSE about 1 yr ago

LoL.....now trading at $0.50 I'd say this will get a RS to satisfy NYSE regs Don't bet the farm ; )
Iseneschal - November 21, 2024

CHRO....NR this a.m after the open...go back to bed ; )

  Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates  ...
Iseneschal - November 21, 2024

CHRO....somebody is buying PM

Just an observation
Iseneschal - November 20, 2024
View more Bullboard ››

GameSquare Holdings Inc.

GameSquare Holdings Inc.

GameSquare Holdings, Inc. is a vertically integrated, digital media, entertainment and technology company. It connects global ...
View More »